Patient)
Tadalafil
This medicine should always be used exactly as described in this patient leaflet or as directed by your doctor or pharmacist.
Tadacontrol is a medicine for adult men with erectile dysfunction. This is a condition where a man cannot achieve or maintain an erection sufficient for sexual intercourse. It has been shown that Tadacontrol significantly improves the ability to achieve an erection sufficient for sexual intercourse.
Tadacontrol contains the active substance tadalafil, which belongs to a group of medicines called phosphodiesterase type 5 inhibitors. After sexual stimulation, Tadacontrol helps to widen the blood vessels of the penis, allowing blood to flow into the penis. As a result, the erection improves. Tadacontrol does not help patients who do not have erectile dysfunction.
It is important to be aware that Tadacontrol does not work without sexual stimulation.
The patient and his partner should arrange foreplay, just like when the patient is not taking erectile dysfunction medication.
If you do not experience improvement after taking the medicine or if you feel worse, you should contact your doctor.
Before taking the medicine, you should carefully read the leaflet and review the attached "Patient Questionnaire". To use the medicine safely, you should answer all the questions in the questionnaire.
Before starting to take Tadacontrol, you should use the questionnaire attached to the packaging. In case of any doubts, you should discuss them with your doctor or pharmacist.
You should remember that sexual activity is associated with a certain risk for patients with heart disease, as it puts an additional strain on the heart. If you have heart problems (including those resulting from the questionnaire that indicate you should not take Tadacontrol due to heart problems), you should inform your doctor.
Before taking the medicine, you should inform your doctor if you have any of the following conditions:
It is not known if Tadacontrol is effective in patients:
If you experience sudden worsening of vision or sudden loss of vision or distorted vision while taking tadalafil, you should stop taking tadalafil and immediately contact your doctor.
In some patients taking tadalafil, worsening or sudden loss of hearing has been observed. Although it is not known if this event is directly related to the use of tadalafil, if you experience worsening or sudden loss of hearing, you should stop taking Tadacontrol and immediately contact your doctor.
Tadacontrol is not intended for use in women.
Tadacontrol should not be used in combination with other oral or topical medicines used to treat erectile dysfunction.
Tadacontrol should not be used in combination with pulmonary arterial hypertension therapies (PAH) using sildenafil or other PDE5 inhibitors.
For 48 hours after taking Tadacontrol, you should not take medicines containing sildenafil used to treat erectile dysfunction or pulmonary hypertension.
Tadacontrol should not be taken if you do not have erectile dysfunction.
Tadacontrol is not intended for use in children and adolescents under 18 years of age.
Before taking Tadacontrol, you should use the questionnaire attached to the packaging. In case of doubts, you should tell your doctor or pharmacist about all the medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
You should not take Tadacontrol if you are taking nitrates.
Tadacontrol may affect the action of some medicines or other medicines may affect the action of Tadacontrol. You should tell your doctor or pharmacist if you are taking any of the following medicines:
In some patients who take blood pressure-lowering medicines, a decrease in blood pressure may occur, especially when standing up quickly or sitting down. If you experience symptoms of low blood pressure (dizziness, fainting, feeling of impending fainting), you should first lie down or sit down and wait for the symptoms to pass; drinking water, taking fresh air, tensing abdominal muscles, or crossing your legs may also help. You should avoid standing up quickly or sitting down.
Information on the effect of alcohol is given in section 3. Grapefruit juice may affect the efficacy of Tadacontrol, and you should exercise caution when consuming it. For more information, you should consult your doctor.
When administered to dogs, a decrease in sperm production in the testes was observed. A decrease in sperm concentration was observed in some men. It is unlikely to lead to infertility.
In some men taking Tadacontrol during clinical trials, dizziness was reported; therefore, you should be aware of your reaction to the tablets before deciding to drive a car or operate machines.
If you have previously been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
This medicine should always be used exactly as described in this patient leaflet or as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
Tadacontrol tablets are intended for oral use only in men. The tablets should be swallowed whole with a small amount of water. The tablets can be taken with or without food.
Recommended doseof the medicine is one 10 mg tablet, taken before planned sexual activity.
Your doctor may recommend a different dosing regimen after consultation.
Tadacontrol should be taken at least 30 minutes before planned sexual activity.
Tadacontrol may still be effective up to 36 hours after taking the tablet.
The medicine is for occasional use, as needed.
Tadacontrol should not be used in combination with other oral or topical medicines used to treat erectile dysfunction.
Tadacontrol should not be used in combination with pulmonary arterial hypertension therapies (PAH) using sildenafil or other PDE5 inhibitors.
For 48 hours after taking Tadacontrol, you should not take medicines containing sildenafil used to treat erectile dysfunction or pulmonary hypertension.
Tadacontrol should not be taken if you do not have erectile dysfunction.
It is essential to be aware that Tadacontrol does not work without sexual stimulation.
The patient and his partner should arrange foreplay, just like when the patient is not taking erectile dysfunction medication.
Consuming alcohol may affect your ability to achieve an erection and may cause transient lowering of blood pressure. If you have taken Tadacontrol or plan to take it, you should not consume large amounts of alcohol (blood alcohol concentration 0.08% or higher), as this may increase the risk of experiencing dizziness when standing up.
You should contact your doctor if you do not experience an erection after taking Tadacontrol or if the duration of the erection is not sufficient for sexual intercourse.
If you have taken a dose higher than recommended, you should inform your doctor. Adverse reactions described in section 4 may occur.
If you have any further doubts about taking the medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
These effects are usually mild or moderate.
Other reported side effects:
Common(observed in 1 to 10 in 10 patients)
Uncommon(observed in 1 to 10 in 100 patients)
Rare(observed in 1 to 10 in 1,000 patients)
Myocardial infarction and stroke have been rarely reported in men taking tadalafil. Most of them had heart problems before starting to take tadalafil.
There have been reports of rare cases of partial, transient, or permanent vision loss or blindness in one or both eyes.
In men taking tadalafil, several additional rare side effectshave been reported, which were not observed during clinical trials. These include:
Dizziness was reported more frequently in men over 75 years old taking tadalafil. Diarrhea was reported more frequently in men over 65 years old taking tadalafil.
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "EXP".
The expiry date refers to the last day of the month.
There are no special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Film-coated tablet.
Light yellow, oval, film-coated tablets, with "10" on one side and "TL" on the other side.
Tadacontrol, film-coated tablets, are packaged in PVC/PVDC/Aluminum blisters, in cardboard boxes.
Pack size: 2 film-coated tablets.
Aurovitas Pharma Polska Sp. z o.o.
ul. Sokratesa 13D lokal 27
01-909 Warsaw
e-mail: medicalinformation@aurovitas.pl
APL Swift Services (Malta) Ltd
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
Generis Farmacêutica, S.A.
Rua João de Deus, 19, Venda Nova
2700-487 Amadora
Portugal
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.